{"id":198171,"date":"2026-08-12T10:36:43","date_gmt":"2026-08-12T05:06:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=198171"},"modified":"2026-08-12T10:36:43","modified_gmt":"2026-08-12T05:06:43","slug":"dr-lal-pathlabs-ltd-share-price-52-week-high-2026-08-12","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-ltd-share-price-52-week-high-2026-08-12\/","title":{"rendered":"Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd.<\/a> traded at Rs 1,963.95, up 0.75% today, after touching a fresh 52-week high of Rs 1,989.35. Its market capitalisation stood at Rs 32,802.69 crore.<\/p>\n<p style=\"margin-top:0!important;\">Dr. Lal Pathlabs Ltd. Share Price was at Rs 1,963.95 on 12 August 2026 at 10:17 AM IST, up Rs 14.70 or 0.75% for the day, after the stock touched a fresh 52-week high of Rs 1,989.35. The company\u2019s market capitalisation stood at Rs 32,802.69 crore, making this one-year high notable in today\u2019s market update.<\/p>\n<p>For investors tracking Dr. Lal Pathlabs Ltd. Share Price Today, the verified data confirms a clear price event: the stock moved above its previous close of Rs 1,949.25, opened at Rs 1,950.15, and traded in a narrow intraday band between Rs 1,950.15 and Rs 1,989.35 before easing from the high. Turnover was Rs 1.25 crore on volume of 6,388 shares.<\/p>\n<p>Why is the stock trending? The supplied data confirms the fresh 52-week peak, but it does not establish a company-specific catalyst behind the move. That still makes Dr. Lal Pathlabs Ltd. Stock News relevant because yearly highs often draw attention from investors screening for price strength, relative valuation and sector positioning. Univest notes that the stock\u2019s P\/E ratio is 31.07, P\/B ratio is 0.45, ROE is -2.89 and ROCE is -0.26, while the Healthcare sector benchmark offers a broader context for comparison. For investors, the next key monitor is whether the stock sustains interest near this 52-week high while its valuation and profitability metrics are assessed against peers and the sector backdrop.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Dr. Lal Pathlabs Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,963.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,949.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 14.7 (+0.75%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,950.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,989.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,950.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6,388<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.25 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,802.69 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,963.95. versus the previous close of Rs 1,949.25, a rise of 0.75%. The stock opened at Rs 1,950.15, reached Rs 1,989.35, touched Rs 1,950.15. Reported volume was 6,388.<\/p>\n<p>Dr. Lal Pathlabs Ltd. Share Price Today shows a confirmed fresh 52-week high, with the stock rising above the previous close and hitting Rs 1,989.35 in intraday trade. The move was positive but measured, with turnover at Rs 1.25 crore and volume at 6,388 shares, indicating active but not extreme participation in this price event.<\/p>\n<p>The stock opened at Rs 1,950.15 versus the previous close of Rs 1,949.25, signalling a mildly positive start. From there, it moved to an intraday high of Rs 1,989.35, which also became the new 52-week high. The day low was Rs 1,950.15, the same as the opening level, which means the session\u2019s weakest price came right at the start before the stock pushed higher.<\/p>\n<p>At the time of the article, Dr. Lal Pathlabs Ltd. Share Price was at Rs 1,963.95, still above the previous close by Rs 14.70. In percentage terms, that translated into a gain of 0.75%. The difference between the current price and the day high also shows that some intraday cooling followed the touch of the 52-week peak, which is common when a stock enters fresh high territory and short-term traders react to the move.<\/p>\n<p>From a pure price action perspective, this is a verified breakout to a new one-year high, even though the stock was trading below the session peak at the time of writing. In Stock Market Today terms, that keeps Dr. Lal Pathlabs Ltd. Share News in focus among 52 Week High Stocks and Market Movers. The next step is to examine whether the underlying fundamentals add support to the attention this price move is getting on Univest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Fundamental_Analysis\"><\/span><strong>Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,802.69 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.07x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. was valued at a P\/E ratio of 31.07x, a P\/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.07x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">65.01x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,374.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,802.69 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 142.81 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,949.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,775.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">71.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,594.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">179.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,561.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\"><strong>NGL Fine-Chem Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NGLFINE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,140.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.91<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 32,802.69 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>Why Investors Are Watching Dr. Lal Pathlabs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock is drawing attention because the verified data combines a fresh one-year high with distinctive valuation and sector-positioning signals. For investors following Stocks in News and Share Price Update screens, the key points are factual and measurable.<\/p>\n<ul>\n<li><strong>Fresh price event:<\/strong> The stock hit a new 52-week high of Rs 1,989.35 and was trading at Rs 1,963.95, up 0.75% on the day.<\/li>\n<li><strong>Intraday structure:<\/strong> The stock opened at Rs 1,950.15, the same as the day low, showing that the upward move developed after the opening trade.<\/li>\n<li><strong>Participation:<\/strong> Turnover stood at Rs 1.25 crore with volume of 6,388 shares.<\/li>\n<li><strong>Fundamental context:<\/strong> Market cap was Rs 32,802.69 crore, P\/E was 31.07 and P\/B was 0.45.<\/li>\n<li><strong>Profitability context:<\/strong> ROE of -2.89 and ROCE of -0.26 were below the supplied Healthcare sector medians and averages.<\/li>\n<li><strong>Sector positioning:<\/strong> The stock\u2019s market capitalisation is far above the supplied same-sector benchmark averages and the displayed peer market caps.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>About Dr. Lal Pathlabs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The supplied data identifies Dr. Lal Pathlabs Ltd. (LALPATHLAB) as a Healthcare sector company. In this article, Univest is focusing strictly on the verified market data tied to the fresh 52-week high event rather than adding unsupplied business descriptions or segment details.<\/p>\n<p>For market participants, the company is currently notable because of its Rs 32,802.69 crore market capitalisation and the fact that Dr. Lal Pathlabs Ltd. Share Price has moved to a new one-year high. Within the supplied Healthcare comparison set, that places the stock in focus not just for price action, but also for how its valuation and return ratios compare with the broader sector and selected peers.<\/p>\n<p>As a result, Dr. Lal Pathlabs Ltd. Latest News in the market is being shaped primarily by the verified 52-week peak, current price behaviour and the contrast between its scale and its reported profitability ratios in this dataset.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Dr_Lal_Pathlabs_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Dr. Lal Pathlabs Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>On Univest, users can track Dr. Lal Pathlabs Ltd. Share Price in real time along with 52-week levels, day range, market capitalisation and other verified stock metrics. That makes it easier to follow whether the stock holds near its fresh 52-week peak or moves away from it during the session.<\/p>\n<p>Univest also helps investors monitor fundamental ratios such as P\/E, P\/B, ROE and ROCE, while placing those numbers beside sector benchmarks and peer comparisons. For anyone following Dr. Lal Pathlabs Ltd. Share Price Today, Dr. Lal Pathlabs Ltd. Stock News and broader Stock Updates, that combined view can be useful for keeping the event in context without turning a price move into a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Dr_Lal_Pathlabs_Ltd_Share_Price\"><\/span><strong>What is the current Dr. Lal Pathlabs Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd. Share Price was Rs 1,963.95 at 10:17 AM IST on 12 August 2026. The stock was up Rs 14.70, or 0.75%, from the previous close of Rs 1,949.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Dr_Lal_Pathlabs_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Dr. Lal Pathlabs Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock is in focus because it touched a fresh 52-week high of Rs 1,989.35 during the session. The supplied data confirms the price event, although it does not establish a company-specific catalyst for the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_fresh_52-week_high_for_Dr_Lal_Pathlabs_Ltd_today\"><\/span><strong>What was the fresh 52-week high for Dr. Lal Pathlabs Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd. touched a fresh 52-week high of Rs 1,989.35 on 12 August 2026. At the article timestamp, the stock was trading at Rs 1,963.95, still above the previous close and in positive territory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Dr_Lal_Pathlabs_Ltd_rise_today\"><\/span><strong>How much did Dr. Lal Pathlabs Ltd. rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock rose by Rs 14.70 on the day, which translated into a gain of 0.75%. It moved from the previous close of Rs 1,949.25 to Rs 1,963.95 while also touching a new yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What does today\u2019s price action show for Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock opened at Rs 1,950.15, which was also the day low, and later climbed to Rs 1,989.35. That pattern shows upward intraday movement after the open, followed by some cooling from the session high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What is the market capitalisation of Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s market capitalisation was Rs 32,802.69 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.81 crore and average of Rs 461.64 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Dr_Lal_Pathlabs_Ltd_valued_versus_the_Healthcare_sector\"><\/span><strong>How is Dr. Lal Pathlabs Ltd. valued versus the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Ltd. had a P\/E of 31.07 versus the sector median of 21.13 and average of 65.01. Its P\/B was 0.45, below the sector median of 1.90 and average of 2.59.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_ROE_and_ROCE_figures_indicate_for_Dr_Lal_Pathlabs_Ltd\"><\/span><strong>What do the ROE and ROCE figures indicate for Dr. Lal Pathlabs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data shows ROE of -2.89 and ROCE of -0.26. Both figures are below the Healthcare sector median ROE of 10.92 and median ROCE of 13.29, adding important context to the stock\u2019s 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_Ltd_compare_with_selected_peers\"><\/span><strong>How does Dr. Lal Pathlabs Ltd. compare with selected peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock\u2019s P\/E of 31.07 is below peers such as Beta Drugs at 71.31 and NGL Fine-Chem at 44.41. However, its ROE and ROCE are weaker than most supplied peers, while market cap is much larger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Dr_Lal_Pathlabs_Ltd_Stock_News\"><\/span><strong>What should investors monitor next in Dr. Lal Pathlabs Ltd. Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may watch whether the stock sustains levels near its fresh 52-week high of Rs 1,989.35. They may also track valuation ratios, return metrics, sector benchmarks and peer positioning as new Dr. Lal Pathlabs Ltd. Stock News develops.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Pathlabs Ltd. Share Price hits a new 52-week high at Rs 1,963.95. marking a 0.75% rise today. Market cap stands at Rs 32,802.69 crore.<\/p>\n","protected":false},"author":29,"featured_media":198170,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-198171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["198170"],"rank_math_title":["Dr. Lal Pathlabs Ltd. Share Price at Fresh 52-Week High"],"rank_math_description":["Dr. Lal Pathlabs Ltd. Share Price hit a fresh 52-week high at Rs 1,989.35. Read price action, valuation, sector and peer analysis."],"rank_math_focus_keyword":["Dr. Lal Pathlabs Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Share_Price_Hits_Fresh_52_Week_High_bullish-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/198171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=198171"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/198171\/revisions"}],"predecessor-version":[{"id":198172,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/198171\/revisions\/198172"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/198170"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=198171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=198171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=198171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}